Sep 2026· Transactions on Artificial Intelligence· Vol 2, pp. 204-213· 0 citations· 27 references
TL;DR
This study proposes a precautionary, multi-level auditing framework designed to assess the structural architectural integrity of large-scale clinical datasets prior to computational deployment, and concludes that structural validation is not an elective procedure but an ethical imperative for Human-Centric Clinical AI.
Abstract
Researchers increasingly rely on Clinical Artificial Intelligence (CAI) to derive predictive insights from massive observational datasets. However, the paradigm of Big Medical Inference often conflates statistical volume with clinical representativeness. This study argues that when methodological rigor is sacrificed for data scale, AI models risk institutionalizing historical biases, thereby compromising patient safety and public health policy integrity. We propose a precautionary, multi-level auditing framework designed to assess the structural architectural integrity of large-scale clinical datasets prior to computational deployment. Rather than contesting specific clinical outcomes, our approach establishes a quantitative prerequisite for CAI: the validation of demographic representativeness and baseline case distribution against official national benchmarks. To demonstrate the validity of our approach, we applied our framework to a prominent, high-profile case study. Our check revealed a tripartite structural divergence: a 32.5% demographic deficit in high-risk elderly (aged ≥ 65 years) strata, an aggregate of approximately 26% cancer incidence suppression, and a 45.1% deflation of expected cases in non-exposed groups. These discrepancies demonstrate that even massive datasets can be fundamentally misaligned with clinical reality. We conclude that structural validation is not an elective procedure but an ethical imperative for Human-Centric Clinical AI. By re-establishing this hierarchy of validation, we ensure that the intelligence of automated AI systems remains subordinate to the structural truth of the data, thereby transitioning from a reliance on Big Data alone toward a more robust, ethically sound, and authentic practice of clinical knowledge.
Modern clinical epidemiology and artificial intelligence are increasingly driven by an idealized premise: the belief that massive databases and advanced machine learning can redeem causal inference from observational uncertainty. Behind the facade of multi-million-record cohorts, however, a profound epistemological cri...
Marco Roccetti· Frontiers in Artificial Inte...· 0 citations
AI Morbidity and Mortality (AI M&M) is intended to complement, rather than replace, model monitoring, patient safety reporting, and regulatory oversight by converting individual AI-in-workflow failures into actionable institutional learning.
Paulius Mui, Dean F. Sittig, Steven Labkoff et al.· 0 citations
A framework through XAI to incorporate various health data sources such as electronic health records, medical imaging, laboratory reports, and wearable sensor information, which can be integrated in the context of achieving higher predictive performance in disease prediction and treatment stratification, as well as dec...
M. Aparna, S. Lahane, Dr. Bharti A. Dixit· Journal of Intelligent Decis...· 0 citations
CareGraph is an auditable hybrid AI framework that converts heterogeneous records into prioritized trends, missing context indicators, bounded next steps, discussion questions, and provenance linked explanations that offers a safety bounded foundation for intelligent personalized health systems.
The clinical integration of artificial intelligence has outpaced the development of robust evaluative frameworks, raising critical safety concerns. This perspective establishes a clear taxonomy distinguishing probabilistic language models from deterministic classifiers and applies a multi-dimensional combinatorial mode...
M. Toma, David Yusupov· Bioengineering· 1 citation
INTRODUCTIONThe evaluation of clinical evidence continues to rely predominantly on measures of statistical significance and relative effect size. Although indispensable, these metrics alone may not adequately characterize evidence quality, particularly with respect to follow-up integrity, clinical relevance, predictive...
F. Masedu, Monica Mazza, M. Attanasio et al.· Epidemiology Biostatistics a...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.